| Financial Year |
March 31 2023 |
| Monetary Funds |
386,582,430.88 |
| Held-for-trading Financial Assets |
412,201,158.12 |
| Notes Receivable |
-- |
| Accounts Receivable |
107,989,602.19 |
| Advances to Suppliers |
787,030.37 |
| Other Receivables |
3,875,103.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,357,989.31 |
| Dividend Receivable |
-- |
| Inventories |
57,050,238.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,775,235.25 |
| Total Current Assets |
1,027,371,951.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,807,411.03 |
| Investment Properties |
-- |
| Fixed Assetes |
125,914,959.99 |
| Under-construction Projects |
246,260,778.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,888,964.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,419,867.55 |
| Other Non-Current Assets |
86,036,174.80 |
| Sub-Total of Non-Current Assets |
569,396,685.65 |
| Total Assets |
1,596,768,636.66 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
104,845,944.94 |
| Accounts Payable |
67,330,714.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,572,086.83 |
| Taxes Payable |
6,046,739.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,988,541.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
576,078.05 |
| Other Current Liabilities |
78,664.05 |
| Sub-Total of Current Liabilities |
190,611,882.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
672,451.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,930,451.59 |
| Total Liabilities |
196,542,334.52 |
| Paid-In Capital(Or Share Stock) |
183,147,692.00 |
| Capital Surplus |
659,555,394.16 |
| Surplus Reserve |
57,088,909.83 |
| LESS:Treasury Stock |
23,461,127.39 |
| Undistributed Profits |
522,102,182.43 |
| Minority Stockholder's Interest |
1,961,022.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,398,265,279.48 |
| Owner's Equity（Stockholder's Equity） |
1,400,226,302.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,596,768,636.66 |
